Influencing factors for intraoperative choking during painless gastrointestinal endoscopy in patients recovered from coronavirus disease 2019_West China Medical Journal

Authors：

JI Wenxuan ¹ , LIU Xin ² ,  GAO Ju ²

1. Department of Anesthesiology, the Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu 225001, P. R. China;
2. Department of Anesthesiology, Northern Jiangsu People’s Hospital, Yangzhou, Jiangsu 225001, P. R. China;

Corresponding author：

GAO Ju, Email: doctor2227@163.com

Keywords：

COVID-19; painless gastrointestinal endoscopy; intraoperative choking; risk factors; protective factors

DOI：

10.7507/1002-0179.202403079

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To determine the independent influencing factors of intraoperative choking during painless gastrointestinal endoscopy (PGIE) after coronavirus disease 2019 (COVID-19). Methods The data of patients undergoing PGIE with COVID-19 in Northern Jiangsu People’s Hospital between December 2022 and April 2023 were retrospectively collected. Multiple logistic regression analysis was used to screen the influencing factors of intraoperative coughing events that occurred during the diagnosis and treatment process. Results A total of 948 patients were included, with 93 (9.8%) cases of choking. The results of the multiple logistic regression analysis showed that smoking and unresolved cough were independent risk factors for coughing (P<0.05), while colonoscopy and infection duration beyond 14 days between diagnosis and treatment were independent protective factors for coughing (P<0.05). Conclusions When patients with COVID-19 undergoing PGIE, special attention should be paid to high-risk groups such as smoking and unresolved cough. It is necessary to strengthen intraoperative monitoring and implementation of prevention and control measures to reduce the incidence of coughing and improve the safety of diagnosis and treatment for patients.

1.	Ren W, Zhu Y, Lan J, et al. Susceptibilities of human ACE2 genetic variants in coronavirus infection. J Virol, 2022, 96(1): e0149221.
2.	郭艺飞, 张继明. 严重急性呼吸综合征冠状病毒 2 Omicron 变异株研究进展. 微生物与感染, 2022, 17(1): 2-8.
3.	Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nat, 2022, 604(7907): 697-707.
4.	中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版). 中国合理用药探索, 2023, 20(1): 1-11.
5.	Mason KP, Green SM, Piacevoli Q. Adverse event reporting tool to standardize the reporting and tracking of adverse events during procedural sedation: a consensus document from the world siva international sedation task force. Br J Anaesth, 2012, 108(1): 13-20.
6.	李涛, 张允岭, 赵晖, 等. 吸烟与脑卒中高危人群颈动脉粥样硬化发生的相关性分析. 中西医结合心脑血管病杂志, 2015, 13(2): 175-178.
7.	梁彪, 胡琳琍, 王芳, 等. 无痛胃镜诊疗的临床应用. 中国内镜杂志, 2006, 12(5): 520-523.
8.	中华医学会麻醉学分会气道管理学组. 新型冠状病毒肺炎危重型患者气管插管术的专家建议 (1.0 版). 中华麻醉学杂志, 2020, 40(3): 287-290.
9.	王梓, 刘昕, 高巨. 老年患者无痛胃肠镜检查术后 PACU 滞留时间延长的危险因素. 中华麻醉学杂志, 2023, 43(2): 146-151.
10.	刘婉君, 陈丽萍. 吸烟对下呼吸道诱导痰中 IFN-γ、IL-4、IL-5 表达的影响. 中国微生态学杂志, 2018, 30(7): 795-797, 801.
11.	祁闻, 李仁奇, 袁亮, 等. 吸烟对无痛胃镜检查男性患者丙泊酚用量的影响. 临床麻醉学杂志, 2018, 34(11): 1092-1094.
12.	杨伟东, 李双月, 江仁, 等. 全身麻醉术后下呼吸道感染相关影响因素分析. 中华医院感染学杂志, 2018, 28(9): 1374-1376.
13.	中华医学会呼吸病学分会哮喘学组. 咳嗽的诊断与治疗指南(2015). 中华结核和呼吸杂志, 2016, 39(5): 323-354.
14.	龙茹华, 秦婷婷, 邵建林. 布地奈德雾化吸入预防感染后咳嗽患者无痛胃镜检查呛咳发生. 昆明医科大学学报, 2018, 39(2): 76-79.
15.	谢金凤. 孟鲁斯特联合雾化吸入治疗小儿感染后咳嗽的疗效观察. 世界最新医学信息文摘, 2021, 21(95): 204-205.
16.	Moscarino S, Kötter F, Brandt M, et al. Influence of different surgical concepts for moderate skeletal class Ⅱ and Ⅲ treatment on the nasopharyngeal airway space. J Craniomaxillofac Surg, 2019, 47(10): 1489-1497.
17.	Kawasuji H, Morinaga Y, Tani H, et al. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19. J Med Virol, 2022, 94(1): 147-153.

1. Ren W, Zhu Y, Lan J, et al. Susceptibilities of human ACE2 genetic variants in coronavirus infection. J Virol, 2022, 96(1): e0149221.
2. 郭艺飞, 张继明. 严重急性呼吸综合征冠状病毒 2 Omicron 变异株研究进展. 微生物与感染, 2022, 17(1): 2-8.
3. Douaud G, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nat, 2022, 604(7907): 697-707.
4. 中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版). 中国合理用药探索, 2023, 20(1): 1-11.
5. Mason KP, Green SM, Piacevoli Q. Adverse event reporting tool to standardize the reporting and tracking of adverse events during procedural sedation: a consensus document from the world siva international sedation task force. Br J Anaesth, 2012, 108(1): 13-20.
6. 李涛, 张允岭, 赵晖, 等. 吸烟与脑卒中高危人群颈动脉粥样硬化发生的相关性分析. 中西医结合心脑血管病杂志, 2015, 13(2): 175-178.
7. 梁彪, 胡琳琍, 王芳, 等. 无痛胃镜诊疗的临床应用. 中国内镜杂志, 2006, 12(5): 520-523.
8. 中华医学会麻醉学分会气道管理学组. 新型冠状病毒肺炎危重型患者气管插管术的专家建议 (1.0 版). 中华麻醉学杂志, 2020, 40(3): 287-290.
9. 王梓, 刘昕, 高巨. 老年患者无痛胃肠镜检查术后 PACU 滞留时间延长的危险因素. 中华麻醉学杂志, 2023, 43(2): 146-151.
10. 刘婉君, 陈丽萍. 吸烟对下呼吸道诱导痰中 IFN-γ、IL-4、IL-5 表达的影响. 中国微生态学杂志, 2018, 30(7): 795-797, 801.
11. 祁闻, 李仁奇, 袁亮, 等. 吸烟对无痛胃镜检查男性患者丙泊酚用量的影响. 临床麻醉学杂志, 2018, 34(11): 1092-1094.
12. 杨伟东, 李双月, 江仁, 等. 全身麻醉术后下呼吸道感染相关影响因素分析. 中华医院感染学杂志, 2018, 28(9): 1374-1376.
13. 中华医学会呼吸病学分会哮喘学组. 咳嗽的诊断与治疗指南(2015). 中华结核和呼吸杂志, 2016, 39(5): 323-354.
14. 龙茹华, 秦婷婷, 邵建林. 布地奈德雾化吸入预防感染后咳嗽患者无痛胃镜检查呛咳发生. 昆明医科大学学报, 2018, 39(2): 76-79.
15. 谢金凤. 孟鲁斯特联合雾化吸入治疗小儿感染后咳嗽的疗效观察. 世界最新医学信息文摘, 2021, 21(95): 204-205.
16. Moscarino S, Kötter F, Brandt M, et al. Influence of different surgical concepts for moderate skeletal class Ⅱ and Ⅲ treatment on the nasopharyngeal airway space. J Craniomaxillofac Surg, 2019, 47(10): 1489-1497.
17. Kawasuji H, Morinaga Y, Tani H, et al. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19. J Med Virol, 2022, 94(1): 147-153.

West China Medical Journal

Latest ArticlesInfluencing factors for intraoperative choking during painless gastrointestinal endoscopy in patients recovered from coronavirus disease 2019

Abstract Full text Figures/Tables Video References Cited by

Format

Content